Rene Rodriguez-Gutierrez

TL;DR: In this paper, the authors evaluated the effect of SGLT-2 inhibitors and GLP-like peptide-1 (GLP-1) receptor agonists in patients with type 2 diabetes at varying cardiovascular and renal risk.

TL;DR: The main epidemiologic characteristics associated with steroid use, with emphasis on the identification of high risk populations, are discussed and the pathophysiology of corticosteroid induced hyperglycemia as well as the pharmacokinetics and pharmacodynamics associated with steroids use are presented.

TL;DR: The extent to which patients’ concerns are elicited across different clinical settings and how shared decision-making tools impact agenda elicitation is described to help clarify the priorities of a clinical encounter.

TL;DR: Low‐quality evidence suggests that sex steroid therapy may increase LDL‐C and TG levels and decrease HDL‐C level in FTM individuals, whereas oral estrogens may increase TG levels in MTF individuals.

TL;DR: Thyroid hormone treatment was associated with decreased risk of pregnancy loss among women with subclinical hypothyroidism, especially those with pre-treatment TSH concentrations of 4.1-10 mIU/L, however, the increased risk of other pregnancy related adverse outcomes calls for additional studies evaluating the safety of thyroid hormone treatment in this patient population.